|
Volumn 52, Issue 4, 2003, Pages 346-348
|
Equivalent single-dose pharmacokinetics of two different dosing methods of prolonged-release fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer
|
Author keywords
Advanced breast cancer; Antiestrogen; Estrogen receptor downregulator; Fulvestrant; Pharmacokinetics
|
Indexed keywords
FULVESTRANT;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BREAST CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
DRUG BLOOD LEVEL;
DRUG INJECTION VOLUME;
DRUG MECHANISM;
DRUG RELEASE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HEADACHE;
HUMAN;
MULTICENTER STUDY;
NAUSEA;
OPEN STUDY;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
AGED;
AGED, 80 AND OVER;
AREA UNDER CURVE;
BREAST NEOPLASMS;
ESTRADIOL;
FEMALE;
HUMANS;
MIDDLE AGED;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
|
EID: 0242267021
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s00280-003-0643-7 Document Type: Article |
Times cited : (21)
|
References (6)
|